Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Cell kinetics in the adult neurogenic niche and impact of diet-induced accelerated aging.

Stankiewicz AJ, Mortazavi F, Kharchenko PV, McGowan EM, Kharchenko V, Zhdanova IV.

J Neurosci. 2019 Feb 8. pii: 2730-18. doi: 10.1523/JNEUROSCI.2730-18.2019. [Epub ahead of print]

PMID:
30737307
2.

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.

Zhong HJ, Sun HH, Xue LF, McGowan EM, Chen Y.

World J Gastroenterol. 2019 Jan 21;25(3):378-387. doi: 10.3748/wjg.v25.i3.378.

3.

An isomiR expression panel based novel breast cancer classification approach using improved mutual information.

Lan C, Peng H, McGowan EM, Hutvagner G, Li J.

BMC Med Genomics. 2018 Dec 31;11(Suppl 6):118. doi: 10.1186/s12920-018-0434-y.

4.

Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Chen H, McGowan EM, Ren N, Lal S, Nassif N, Shad-Kaneez F, Qu X, Lin Y.

Biomark Insights. 2018 Jul 5;13:1177271918785130. doi: 10.1177/1177271918785130. eCollection 2018. Review.

5.

The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?

Moulder DE, Hatoum D, Tay E, Lin Y, McGowan EM.

Cancers (Basel). 2018 Jun 8;10(6). pii: E189. doi: 10.3390/cancers10060189. Review.

6.

Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.

McGowan EM, Lin Y, Hatoum D.

Cancers (Basel). 2018 May 31;10(6). pii: E172. doi: 10.3390/cancers10060172. Review.

7.

Kinase-targeted cancer therapies: progress, challenges and future directions.

Bhullar KS, Lagarón NO, McGowan EM, Parmar I, Jha A, Hubbard BP, Rupasinghe HPV.

Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2. Review.

8.

PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.

Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM.

Mol Cancer. 2018 Feb 19;17(1):37. doi: 10.1186/s12943-018-0803-3. Review.

9.

Assessment of FGFR1 Over-Expression and Over-Activity in Lung Cancer Cells: A Toolkit for Anti-FGFR1 Drug Screening.

Hu P, Chen H, McGowan EM, Ren N, Xu M, Lin Y.

Hum Gene Ther Methods. 2018 Feb;29(1):30-43. doi: 10.1089/hgtb.2017.104. Epub 2018 Jan 26.

PMID:
29281903
10.

Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Boonyaratanakornkit V, Hamilton N, Márquez-Garbán DC, Pateetin P, McGowan EM, Pietras RJ.

Mol Cell Endocrinol. 2018 May 5;466:51-72. doi: 10.1016/j.mce.2017.11.010. Epub 2017 Nov 14. Review.

PMID:
29146555
11.

Impaired Sleep, Circadian Rhythms and Neurogenesis in Diet-Induced Premature Aging.

Stankiewicz AJ, McGowan EM, Yu L, Zhdanova IV.

Int J Mol Sci. 2017 Oct 26;18(11). pii: E2243. doi: 10.3390/ijms18112243.

12.

"Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.

Haddadi N, Lin Y, Simpson AM, Nassif NT, McGowan EM.

Int J Mol Sci. 2017 Sep 2;18(9). pii: E1891. doi: 10.3390/ijms18091891. Review.

13.

Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.

Hatoum D, Haddadi N, Lin Y, Nassif NT, McGowan EM.

Oncotarget. 2017 May 30;8(22):36898-36929. doi: 10.18632/oncotarget.16370. Review.

14.

Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.

Hatoum D, Yagoub D, Ahadi A, Nassif NT, McGowan EM.

PLoS One. 2017 Jan 9;12(1):e0169925. doi: 10.1371/journal.pone.0169925. eCollection 2017.

15.

Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening.

Udommethaporn S, Tencomnao T, McGowan EM, Boonyaratanakornkit V.

PLoS One. 2016 Jul 14;11(7):e0159151. doi: 10.1371/journal.pone.0159151. eCollection 2016.

16.

Hijacking of Endocrine and Metabolic Regulation in Cancer and Diabetes.

McGowan EM, Simpson A, McManaman J, Boonyaratanakornkit V, Hardikar AA.

Biomed Res Int. 2015;2015:386203. doi: 10.1155/2015/386203. Epub 2015 Jul 9. No abstract available.

17.

Recent advances in the use of metformin: can treating diabetes prevent breast cancer?

Hatoum D, McGowan EM.

Biomed Res Int. 2015;2015:548436. doi: 10.1155/2015/548436. Epub 2015 Mar 19. Review.

18.

Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.

Haass NK, Nassif N, McGowan EM.

Biomed Res Int. 2015;2015:165105. doi: 10.1155/2015/165105. Epub 2015 Mar 19. Review.

19.

Sphingosine kinase 1 isoform-specific interactions in breast cancer.

Yagoub D, Wilkins MR, Lay AJ, Kaczorowski DC, Hatoum D, Bajan S, Hutvagner G, Lai JH, Wu W, Martiniello-Wilks R, Xia P, McGowan EM.

Mol Endocrinol. 2014 Nov;28(11):1899-915. doi: 10.1210/me.2013-1423. Epub 2014 Sep 12.

20.

p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis?

McGowan EM, Tran N, Alling N, Yagoub D, Sedger LM, Martiniello-Wilks R.

PLoS One. 2012;7(7):e42246. doi: 10.1371/journal.pone.0042246. Epub 2012 Jul 30.

21.

Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.

McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R.

PLoS One. 2011;6(6):e20623. doi: 10.1371/journal.pone.0020623. Epub 2011 Jun 3.

22.

Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity.

Martin JL, Lin MZ, McGowan EM, Baxter RC.

J Biol Chem. 2009 Sep 18;284(38):25542-52. doi: 10.1074/jbc.M109.007120. Epub 2009 Jul 25.

23.

BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate.

Matsuda S, Giliberto L, Matsuda Y, McGowan EM, D'Adamio L.

J Neurosci. 2008 Aug 27;28(35):8668-76. doi: 10.1523/JNEUROSCI.2094-08.2008.

24.

Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.

McGowan EM, Russell AJ, Boonyaratanakornkit V, Saunders DN, Lehrbach GM, Sergio CM, Musgrove EA, Edwards DP, Sutherland RL.

Cancer Res. 2007 Sep 15;67(18):8942-51.

25.

Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.

Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE.

J Clin Invest. 2006 Jan;116(1):193-201. Epub 2005 Dec 8.

26.

Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.

McGowan EM, Saad S, Bendall LJ, Bradstock KF, Clarke CL.

Breast Cancer Res Treat. 2004 Feb;83(3):211-20.

PMID:
14758091
27.

Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels.

McGowan EM, Weinberger RP, Graham JD, Hill HD, Hughes JA, O'Neill GM, Clarke CL.

J Mol Endocrinol. 2003 Oct;31(2):241-53.

PMID:
14519093
28.

Non-radioactive in situ hybridization using alkaline phosphatase-labelled oligonucleotides.

Augood SJ, McGowan EM, Finsen BR, Heppelmann B, Emson PC.

Int Rev Neurobiol. 2002;47:173-201. Review. No abstract available.

PMID:
12198799
29.

Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma.

Mote PA, Balleine RL, McGowan EM, Clarke CL.

Hum Reprod. 2000 Aug;15 Suppl 3:48-56.

PMID:
11041221
30.

Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs.

Hale JJ, Mills SG, MacCoss M, Dorn CP, Finke PE, Budhu RJ, Reamer RA, Huskey SE, Luffer-Atlas D, Dean BJ, McGowan EM, Feeney WP, Chiu SH, Cascieri MA, Chicchi GG, Kurtz MM, Sadowski S, Ber E, Tattersall FD, Rupniak NM, Williams AR, Rycroft W, Hargreaves R, Metzger JM, MacIntyre DE.

J Med Chem. 2000 Mar 23;43(6):1234-41.

PMID:
10737756
31.

Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogs.

Huskey SE, Luffer-Atlas D, Dean BJ, McGowan EM, Feeney WP, Chiu SH.

Drug Metab Dispos. 1999 Nov;27(11):1367-73.

PMID:
10534323
32.
33.

Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle.

Mote PA, Balleine RL, McGowan EM, Clarke CL.

J Clin Endocrinol Metab. 1999 Aug;84(8):2963-71.

PMID:
10443705
34.
35.

Regional and cellular localization of presenilin-2 RNA in rat and human brain.

Benkovic SA, McGowan EM, Rothwell NJ, Hutton M, Morgan DG, Gordon MN.

Exp Neurol. 1997 Jun;145(2 Pt 1):555-64.

PMID:
9217091
36.
37.

Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus.

McGowan EM, Hayden MB, Edwards SJ, Pye D, Love DN, Whalley JM.

Arch Virol. 1994;137(3-4):389-95.

PMID:
7944958
38.
40.

Menthol urticaria.

McGowan EM.

Arch Dermatol. 1966 Jul;94(1):62-3. No abstract available.

PMID:
5938225

Supplemental Content

Loading ...
Support Center